Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2010-09-22
Original market date: See footnote 1
2010-04-28
Product name:
VAGIFEM 10
DIN:
02325462
Product Monograph/Veterinary Labelling:
Date:
2023-11-01
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
NOVO NORDISK CANADA INC
101-2476 Argentia Road
Mississauga
Ontario
Canada
L5N 6M1
Class:
Human
Dosage form(s):
Vaginal Tablet
Route(s) of administration:
Vaginal
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:16.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03CA03 ESTRADIOL
Active ingredient group (AIG) number:See footnote5
0106457031
| Active ingredient(s) | Strength |
|---|---|
| ESTRADIOL (ESTRADIOL HEMIHYDRATE) | 10 MCG |